Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule 13D with respect to the common stock, $0.0001 par value per share of Vaccinogen, Inc., and that this agreement be included as Exhibit 99.1 to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: September 2, 2014

/s/ Stephen W. Robinson

Name: Stephen W. Robinson

/s/ Jeanne M. Robinson

Name: Jeanne M. Robinson